Aoxing Pharmaceutical Company Appoints BDO China Dahua as Its Independent Auditor

Aoxing Pharmaceutical Company, Inc. /quotes/zigman/620050/quotes/nls/axn AXN 0.00% ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing, and distribution of narcotic, pain-management, and addiction treatment pharmaceuticals, today announced the appointment of BDO China Dahua as its independent auditor. The appointment of BDO China Dahua as independent registered accounting firm has been approved by the Audit Committee of Aoxing Pharma's Board of Directors. Aoxing Pharma wishes to thank Paritz & Company, P.A. for its service as independent auditor over the years. About Aoxing Pharmaceutical Company, Inc. Aoxing Pharmaceutical Company, Inc. is a US incorporated specialty pharmaceutical company with its operations in China, specializing in research, development, manufacturing and distribution of a variety of narcotics and pain-management products. Headquartered in Shijiazhuang City, outside Beijing, Aoxing Pharma has the largest and most advanced manufacturing facility in China for highly regulated narcotic medicines. Its facility is one of the few GMP facilities licensed for the manufacture of narcotic medicines by the China State Food and Drug Administration (SFDA). It has a joint venture collaboration with Johnson Matthey Plc to produce and market narcotics and neurological drugs in China. It also has strategic alliance partnerships with QRxPharma, and Phoenix PharmaLabs, Inc.